Abattis Bioceuticals Acquires Distribution Rights to Cultivation Products
Ryan Allway
February 19th, 2014
News, Top Story
Abattis Bioceuticals Corp. (OTC Pink: ATTBF) (CSE: FLU), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, has made tremendous progress in bringing its vertical cultivation, extraction, and strategic support products & services to market.
This week, the company announced that it acquired exclusive worldwide distribution rights to Jiangsu Jiahui New Material Co. Ltd.’s innovative magnesium oxide products for use in any building or facility designed to cultivate botanicals. The construction products are made from MgO fiberglass with infill materials of sawdust, fly ash and slag, and proprietary compounds in order to be structurally sound, and highly resistant to fire, moisture, bugs, mold and microbes.
Read the full press release discussing the new agreement here:
Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTC PINK: ATTBF) (CSE:FLU), through its wholly owned subsidiary, Biocube Green Grow Systems Corp. announces the company has acquired the Exclusive World Wide Distribution Rights to Jiangsu Jiahui New Material Co Ltd’s. innovative MgO (Magnesium Oxide) products for use in any building or facility designed to cultivate botanicals.
MgO construction products are made from MgCl2, MgO, fiberglass with infill materials of sawdust, fly ash and slag and proprietary compounds. MgO construction products are structural, highly resistant to fire, moisture, bugs, mold and microbes and are resilient to environmental-aging. Compared to other traditional construction material it is longer-usage life, and can be recycled as a green product. From years of researching and development of the product, the IP and products are protected with 10-patented, and 1 product is protected by a USPTO Patent.
The MgO products come in boards and can be used for flooring, exterior walls, interior walls, floor sheathing, available for use in SIPs, ceiling and even cabinetry. They also are used for exterior and interior walls. The outer layers of the SIP are typically comprised of 10-15 mm thick boards. MgO infill is injected in the special region between the boards of every Sandwich Panel. These are made in the factory in China using proprietary ingredients that ensure consistent bonding strength from board to board. Class A for Fire Rating and are extremely strong and durable.
“We are excited to have the exclusive rights to this innovative product that offers unique performance features that are well suited for our Controlled Cultivation Environment design. The products are energy efficient and when assembled, deliver a superior Controlled Cultivation EnvironmentTM “CCE” that increase yields for medicinal plants and food while eliminating destructive pests that kill crops and profit,” said Mr. Michael Withrow, Abattis’ chief executive officer. He went on to say, “The CCE is a key component that compliments our Vertical Growing systems. We continue to acquire the necessary pieces to ensure that Abattis through its wholly owned subsidiaries, can deliver low cost, efficacious, safe solutions that work.”
Under the terms of the agreement Abattis has paid 100,000 shares as consideration for the exclusive rights to distribute the products for use in Greenhouse and Growing facilities. The term of the exclusivity is 5 years. There is a finder’s fee of 10,000 shares payable for the transaction.
ON BEHALF OF THE BOARD
“Mike Withrow”
Michael Withrow, President & CEO
About Abattis Bioceuticals Corp.
Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The company is positioned to capitalize on the fast growing trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions by supplying and partnering with companies to employ its vertical cultivation systems, extraction equipment/technology, and strategic marketing support to licensed growers. The company also has an extensive pipeline of high-quality products and Intellectual Property for the rapidly expanding botanical drug market. We follow strict Standard Operating Protocols and adhere to the Law’s of Canada and Foreign Jurisdictions. For more information, visit the Company’s website atwww.abattis.com.
For further information, contact the Company’s CEO, Michael Withrow at (778) 896-6536 or at mike.withrow@abattis.com.
About Jiangsu Jiahui New Material Co Ltd.
Jiangsu Jiahui New Materials Co. Ltd. is a leading Global Manufacturer of MgO based products located in Nanjing, China. The company specializes in manufacturing MgO Panels for walls, siding, and sandwich panels (SIPs). From years of researching and development of magesia-based products the company is recognized by Jiangsu technology organization as a High-Tech production company.
For more information, visit the Company’s website at http://www.jiahuimgo.com
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
FORWARD LOOKING INFORMATION
This press release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s Discussion and Analysis under the Company’s profile on www.sedar.com. While the Company may elect to, it does not undertake to update this information at any particular time.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
The Yield Growth Corp. is a diverse team of business executives dedicated to rapid, sustainable financial growth for businesses with viable models for success.
Xphyto Therapeutics Corp. was created to bridge the gap between traditional cannabis-based medicine and modern scientific approaches to therapeutic validation.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
